Page last updated: 2024-09-03

l 012 and angiotensin ii

l 012 has been researched along with angiotensin ii in 1 studies

Compound Research Comparison

Studies
(l 012)
Trials
(l 012)
Recent Studies (post-2010)
(l 012)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
2401038,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomyl 012 (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandes, RP; Daiber, A; Förstermann, U; Hink, U; Hortmann, M; Kleschyov, AL; Li, H; Mollnau, H; Mülsch, A; Münzel, T; Oelze, M; Schulz, E; von Sandersleben, A; Wenzel, P1

Other Studies

1 other study(ies) available for l 012 and angiotensin ii

ArticleYear
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:4

    Topics: Acridines; Adrenergic beta-Antagonists; Angiotensin II; Animals; Benzopyrans; Blood Vessels; Cell Line; Cyclic GMP; Dicarbethoxydihydrocollidine; Endothelium, Vascular; Ethanolamines; Fluorescence; Hemoglobins; Humans; Luminescence; Luminescent Agents; Luminol; Male; Myocardium; NADPH Oxidases; Nebivolol; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Phosphoproteins; rac1 GTP-Binding Protein; Rats; Rats, Wistar; Signal Transduction; Superoxides

2006